Short Interest in Arcadia Biosciences, Inc. (NASDAQ:RKDA) Expands By 1,175.8%

Posted by Stacy Sanders on Dec 27th, 2024

Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 116,100 shares, an increase of 1,175.8% from the November 30th total of 9,100 shares. Based on an average daily trading volume, of 1,150,000 shares, the short-interest ratio is currently 0.1 days. Approximately 8.5% of the shares of the company are short sold.

Arcadia Biosciences Stock Down 0.7 %

RKDA traded down $0.04 during trading on Friday, reaching $6.11. 69,202 shares of the company’s stock were exchanged, compared to its average volume of 315,605. The company has a market capitalization of $8.34 million, a P/E ratio of -1.43 and a beta of 1.18. The business has a 50 day moving average price of $4.40 and a 200 day moving average price of $3.43. Arcadia Biosciences has a fifty-two week low of $1.85 and a fifty-two week high of $10.31.

Analyst Upgrades and Downgrades

Separately, StockNews.com initiated coverage on shares of Arcadia Biosciences in a report on Wednesday. They issued a “sell” rating for the company.

View Our Latest Stock Report on Arcadia Biosciences

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.